An outbreak investigation can disappear from public view for several very different reasons. Investigators may identify a product and issue advice. The risk may pass before a vehicle is found. Evidence may point to a food without supporting a useful consumer action. Or the active response may end while inspections, root-cause work and prevention continue.
FDA’s newly released CORE+EP 2025 annual report helps make that workflow visible. The agency says its Signals and Surveillance Team evaluated 69 incidents during 2025. Twenty-six responses were initiated, and 11 public-health advisories were issued. FDA CORE+EP 2025 report
Those numbers are not a scorecard in which every evaluation should become an advisory.
The funnel reflects different questions
The Signals Team examines possible outbreaks, confirmed outbreaks and some adverse-event series. It works with CDC, USDA, state agencies and other FDA offices, reviewing epidemiology alongside company information, inspections, sampling, distribution, sourcing and prior food-pathogen incidents.
An incident moves to a response team when the evidence suggests an FDA-regulated food. Some signals instead belong to USDA or another authority. Some never yield a specific vehicle. A response may identify a food but still lack a current, actionable step for consumers.
Eli’s analysis: “No advisory” is not the same as “no investigation,” and “investigation closed” is not the same as “nothing learned.” The public-facing categories describe decisions at particular points in an evidence process. They should not be treated as verdicts on whether illness occurred or whether agencies worked.
FDA also warns that its investigation table is not the whole foodborne-disease universe. It excludes shellfish-related events handled elsewhere, animal and pet-food incidents, and foods regulated by USDA’s Food Safety and Inspection Service. Comparing the table with a national illness estimate would therefore mix unlike denominators.
Prevention begins after the source is named
When investigators link illnesses to a food, agencies can issue advice and support recalls. FDA may also use warning letters, import alerts, seizure or injunction. Other offices can conduct inspections, reassess risk or build prevention strategies.
The report highlights newer post-response products. Executive Incident Summary abstracts describe major steps in completed investigations within disclosure limits. Foodborne Outbreak Overview of Data reports examine food-pathogen pairs implicated repeatedly, combining epidemiology, laboratory findings, traceback and prevention activity.
Our interpretation: The most consequential question is often not “Was there a recall?” It is “What control failed, and what changed afterward?” A useful prevention record should identify the hypothesized route of contamination, evidence strength, corrective action, responsible party, verification method and whether the same food-pathogen pair returns.
That is difficult because traceback can involve farms, processors, ingredient suppliers, distributors, restaurants and homes. Multi-ingredient foods add another problem: identifying a finished product does not automatically identify the contaminated ingredient.
Count learning, not only alerts
Public accountability could improve with measures that follow an incident beyond closure:
- time from first signal to interagency assessment;
- proportion of illnesses with usable purchase or exposure information;
- time to product and ingredient hypotheses;
- corrective actions verified after inspection;
- recurring food-pathogen pairs;
- publication of a summary when disclosure rules allow; and
- prevention recommendations adopted and checked over time.
None of those measures should reward premature certainty. A fast but wrong attribution can harm consumers and businesses while missing the actual source. Transparency should show uncertainty and corrections, not erase them.
The workforce is broad: local disease investigators, state epidemiologists, laboratorians, environmental-health specialists, federal coordinators, inspectors, data analysts, veterinarians, food scientists, supply-chain experts and risk communicators. For students, a weekly table is the visible edge of a much larger system.
Explore TiPH’s human topics, careers hub, learning hub and investigation guide.
Uncertainty and reporting: FDA’s 69 evaluations, 26 responses and 11 advisories are workflow activities during 2025, not counts of unique outbreaks occurring wholly within that year, illness totals or performance rates. Incident lifespans can cross calendar years, and the report excludes food categories handled by other authorities. TiPH did not interview FDA, state investigators, companies or affected people. AI assisted research and drafting; Elijah St. John approved publication on October 14, 2026.
Persona disclosure. Eli Ward is a recurring editorial pen-name persona used by Today in Public Health for policy, workforce and systems analysis. It is not a real individual; no biography, credentials, employment history, lived experience or on-location reporting is implied. AI assisted the research and drafting of this article, and Elijah St. John reviewed and approved it for publication. The persona is not an expert source.
Related on TiPH: Global Signal Scan, October 14, 2026 · Latest news · How we verify signals